Ketorine DX Eye Drops contain Ketorolac 0.5% w/v + Dexamethasone 0.1% w/v, a dual-action ophthalmic formulation designed to treat ocular inflammation, pain, and post-operative eye conditions. Its combination provides rapid relief and symptom control through NSAID and steroidal action.
Ketorolac acts as a non-steroidal anti-inflammatory agent, reducing pain and inflammation, while Dexamethasone provides potent steroidal anti-inflammatory action, helping prevent tissue damage and accelerating recovery.
From a commercial perspective, Ketorine DX Eye Drops are a high-prescription ophthalmic anti-inflammatory product, commonly used in eye hospitals, clinics, and post-operative care centers, ensuring steady market demand and repeat prescriptions.
Adding Ketorine DX Eye Drops to your portfolio strengthens the ophthalmic steroid-NSAID segment, offering long-term growth, prescriber confidence, and enhanced portfolio credibility for PCD pharma franchise partners.
Common side effects may include mild stinging or burning sensation, temporary blurred vision, eye irritation, or dryness. Rarely, prolonged use may lead to increased intraocular pressure, cataract formation, secondary eye infections, or allergic reactions.
Ketorine DX Eye Drops are indicated for the treatment of ocular inflammation associated with pain, redness, or irritation, including post-operative inflammation, allergic conjunctivitis, and other inflammatory eye disorders. Use is recommended under the supervision of an ophthalmologist.
Use Ketorine DX Eye Drops strictly as prescribed by an ophthalmologist. Avoid contact between the dropper tip and the eye to prevent contamination. Do not use for extended periods without medical supervision. Discontinue and consult a doctor if severe irritation, vision changes, or allergic reactions occur.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.